BPC-157 for gut health support during GLP-1 therapy
Since early 2022 women are calling me, texting me and asking me daily thanks to misleading marketing scams in my profession about the latest weight loss shot or Skinny Shot semaglutide, or Ozempic I felt compelled to post the research of the Other side of the shot like Ozempic Face, Rebound Weight Gain, Dependency, Gallbladder Disease, Thyroid Cancer, Diabetic Retinopathy, Immune Response, Autoimmunity to endogenous GLP-1, Nausea, Vomiting, Diarrhea, GI Adverse side effects, loss of lean muscle, appetite control, eating behavior changes, intestinal obstruction, serious allergic reaction, anaphylaxis, increased heart rate, increased hospitalization for heart failure, potential kidney failure, unknown long term cardiac risk from stimulating the GLP-1 receptors in the heart and increasing heart rate over the long term, rats given semaglutide had increased thyroid and endocrine system cancer [1-13]

Efficacy of Metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial
And these might also be confounding factors when I think about it, since patients with these Ed prone conditions are more likely than to use GLP-1 agonists
Medical weight loss is effective because it targets these biological processes